Sign in Sign up for free

Free Stock Screener

Load
Save
Create a watchlist Help
 
–
×
–
×
–
×
–
×
–
×
–
×
–
×
–
day ×
–
day ×
–
% ×
–
% ×
×
–
×
–
×
–
×
–
×
–
×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
day ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
% ×
–
×
–
×
–
×
–
% ×
–
×
–
×
–
% ×
–
×
–
×
–
×
–
×
–
×

CRVL
Corvel Corp.
Compare

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Current assets
Cash $225.93 $193.705 $187.832 $181.876
Short term investments
Net receivables $97.749 $97.108 $92.657 $86.937
Inventory
Total current assets $333.258 $302.231 $294.392 $281.875
Long term investments
Property, plant & equipment $110.106 $109.95 $110.299 $112.113
Goodwill & intangible assets $37.53 $37.635 $37.741 $37.847
Total noncurrent assets $152.914 $152.448 $150.603 $152.242
Total investments
Total assets $486.172 $454.679 $444.995 $434.117
Current liabilities
Accounts payable $18.681 $16.631 $15.133 $15.356
Deferred revenue
Short long term debt
Total current liabilities $200.585 $184.499 $188.387 $186.499
Long term debt $21.714 $22.533 $23.078 $25.049
Total noncurrent liabilities $21.714 $22.533 $23.078 $25.049
Total debt $21.714 $22.533 $23.078 $25.049
Total liabilities $222.299 $207.032 $211.465 $211.548
Stockholders' equity
Retained earnings $829.497 $807.92 $788.466 $771.371
Other stockholder equity
Total stockholder equity $263.873 $247.647 $233.53 $222.569
(in millions USD) 2024 2023 2022
Current assets
Cash $193.705 $151.351 $167.285
Short term investments
Net receivables $97.108 $81.034 $82.586
Inventory
Total current assets $302.231 $243.77 $264.994
Long term investments
Property, plant & equipment $109.95 $110.491 $111.288
Goodwill & intangible assets $37.635 $38.058 $38.483
Total noncurrent assets $152.448 $150.153 $150.252
Total investments
Total assets $454.679 $393.923 $415.246
Current liabilities
Accounts payable $16.631 $15.309 $14.431
Deferred revenue
Short long term debt
Total current liabilities $184.499 $167.887 $171.37
Long term debt $22.533 $23.86 $29.792
Total noncurrent liabilities $22.533 $23.86 $31.481
Total debt $22.533 $23.86 $29.792
Total liabilities $207.032 $191.747 $202.851
Stockholders' equity
Retained earnings $807.92 $731.668 $665.303
Other stockholder equity
Total stockholder equity $247.647 $202.176 $212.395

Income statement

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Revenue
Total revenue $211.722 $207.233 $202.303 $195.522
Cost of revenue $163.567 $163.83 $160.143 $151.27
Gross profit $48.155 $43.403 $42.16 $44.252
Operating activities
Research & development
Selling, general & administrative $20.12 $20.806 $19.798 $19.538
Total operating expenses $20.12 $20.806 $19.798 $19.538
Operating income $28.035 $22.597 $22.362 $24.714
Income from continuing operations
EBIT $28.035 $22.597 $22.362 $24.714
Income tax expense $6.458 $3.143 $5.267 $4.816
Interest expense
Net income
Net income $21.577 $19.454 $17.095 $19.898
Income (for common shares) $21.577 $19.454 $17.095 $19.898
(in millions USD) 2024 2023 2022
Revenue
Total revenue $795.311 $718.562 $646.23
Cost of revenue $623.618 $560.303 $494.116
Gross profit $171.693 $158.259 $152.114
Operating activities
Research & development
Selling, general & administrative $76.592 $73.705 $67.602
Total operating expenses $76.592 $73.705 $67.602
Operating income $95.101 $84.554 $84.512
Income from continuing operations
EBIT $95.101 $84.554 $84.512
Income tax expense $18.849 $18.189 $18.102
Interest expense
Net income
Net income $76.252 $66.365 $66.41
Income (for common shares) $76.252 $66.365 $66.41

Cash flows

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Net income $21.577 $19.454 $17.095 $19.898
Operating activities
Depreciation $6.726 $6.683 $6.744 $6.461
Business acquisitions & disposals
Stock-based compensation $1.07 $1.292 $1.077 $1.301
Total cash flows from operations $40.439 $15.245 $29.373 $17.993
Investing activities
Capital expenditures -$7.673 -$10.047 -$6.917 -$7.227
Investments
Total cash flows from investing -$7.673 -$10.047 -$6.917 -$7.227
Financing activities
Dividends paid
Sale and purchase of stock -$6.421 -$6.293 -$7.211 -$5.946
Net borrowings
Total cash flows from financing -$6.421 -$6.629 -$7.211 -$5.61
Effect of exchange rate
Change in cash and equivalents $26.345 -$1.431 $15.245 $5.156
(in millions USD) 2024 2023 2022
Net income $76.252 $66.365 $66.41
Operating activities
Depreciation $26.252 $25.121 $23.916
Business acquisitions & disposals
Stock-based compensation $4.982 $5.559 $5.198
Total cash flows from operations $99.237 $82.288 $67.222
Investing activities
Capital expenditures -$29.24 -$26.32 -$29.819
Investments
Total cash flows from investing -$29.24 -$26.32 -$29.819
Financing activities
Dividends paid
Sale and purchase of stock -$35.763 -$82.143 -$79.615
Net borrowings
Total cash flows from financing -$35.763 -$82.143 -$79.615
Effect of exchange rate
Change in cash and equivalents $34.234 -$26.175 -$42.212

GRVY
Gravity Co Ltd
Compare

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions KRW) 29 Jun 2022 30 Mar 2022 30 Dec 2021 29 Sep 2021
Current assets
Cash ₩112,748 ₩101,369 ₩99,104.943 ₩118,173
Short term investments ₩170,000 ₩165,000 ₩148,598.099 ₩108,000
Net receivables ₩53,614 ₩51,863 ₩53,695.111 ₩82,082
Inventory
Other current assets ₩2,644 ₩2,489 ₩2,433.318 ₩3,958
Total current assets ₩341,308 ₩322,729 ₩306,134.92 ₩314,274
Long term investments ₩3,347 ₩3,036 ₩3,018.823 ₩2,388
Property, plant & equipment ₩10,700 ₩10,310 ₩11,337.999 ₩10,307
Goodwill
Intangible assets ₩3,849 ₩3,071 ₩3,342.028 ₩3,400
Other assets ₩2,833 ₩3,147 ₩3,692.553 ₩2,365
Total assets ₩362,037 ₩342,293 ₩327,526.323 ₩332,734
Current liabilities
Accounts payable ₩44,116 ₩40,355 ₩41,199.401 ₩56,702
Short long term debt
Other current liabilities ₩23,618 ₩26,203 ₩27,707.09 ₩22,867
Total current liabilities ₩73,208 ₩72,815 ₩73,997.475 ₩80,923
Long term debt
Other liabilities ₩89 ₩98 ₩1,564.392 ₩6,377
Minority interest ₩651 ₩682 ₩769.951 ₩771
Total liabilities ₩79,392 ₩78,731 ₩80,685.465 ₩87,300
Stockholders' equity
Common stock ₩3,474 ₩3,474 ₩3,474.45 ₩3,474
Retained earnings ₩247,214 ₩229,749 ₩213,317.805 ₩212,053
Treasury stock ₩4,208 ₩2,559 ₩2,180.388 ₩2,037
Capital surplus ₩27,098 ₩27,098 ₩27,098.264 ₩27,099
Total stockholder equity ₩281,994 ₩262,880 ₩246,070.907 ₩244,663
Net tangible assets ₩278,145 ₩259,809 ₩242,728.879 ₩241,263
(in millions KRW) 2021 2020 2019
Current assets
Cash ₩99,104.943 ₩110,632.482 ₩79,427.979
Short term investments ₩148,598.099 ₩71,817.825 ₩39,732.676
Net receivables ₩53,695.111 ₩59,769.589 ₩32,309.673
Inventory
Other current assets ₩2,433.318 ₩3,404.993 ₩3,429.068
Total current assets ₩306,134.92 ₩246,585.717 ₩155,863.353
Long term investments ₩3,018.823 ₩1,323.865 ₩1,769.84
Property, plant & equipment ₩11,337.999 ₩7,695.046 ₩6,663.444
Goodwill
Intangible assets ₩3,342.028 ₩3,362.879 ₩1,717.06
Other assets ₩3,692.553 ₩6,404.861 ₩9,411.648
Total assets ₩327,526.323 ₩265,372.368 ₩175,425.345
Current liabilities
Accounts payable ₩41,199.401 ₩52,687.616 ₩37,496.038
Short long term debt
Other current liabilities ₩27,707.09 ₩26,014.709 ₩15,130.566
Total current liabilities ₩73,997.475 ₩82,720.222 ₩55,787.148
Long term debt
Other liabilities ₩1,564.392 ₩2,057.058 ₩863.568
Minority interest ₩769.951 ₩437.141 ₩221.351
Total liabilities ₩80,685.465 ₩88,024.352 ₩59,659.255
Stockholders' equity
Common stock ₩3,474.45 ₩3,474.45 ₩3,474.45
Retained earnings ₩213,317.805 ₩147,371.155 ₩84,668.067
Treasury stock ₩2,180.388 -₩1,044.533 ₩274.538
Capital surplus ₩27,098.264 ₩27,109.803 ₩27,127.684
Total stockholder equity ₩246,070.907 ₩176,910.875 ₩115,544.739
Net tangible assets ₩242,728.879 ₩173,547.996 ₩113,827.679

Income statement

XSLX
XSLX
(in millions KRW) 29 Jun 2022 30 Mar 2022 30 Dec 2021 29 Sep 2021
Revenue
Total revenue ₩96,519 ₩88,607 ₩96,597.974 ₩128,670
Cost of revenue ₩50,575 ₩45,254 ₩54,631.902 ₩66,146
Gross profit ₩45,944 ₩43,353 ₩41,966.072 ₩62,524
Operating activities
Research & development ₩2,956 ₩3,232 ₩4,270.508 ₩4,143
Selling, general & administrative ₩21,207 ₩17,642 ₩24,921.88 ₩18,091
Total operating expenses ₩74,404 ₩66,291 ₩86,386.079 ₩88,428
Operating income ₩22,115 ₩22,316 ₩10,211.895 ₩40,242
Income from continuing operations
Net other income ₩1,759 ₩904 -₩353.363 ₩1,193
EBIT ₩22,115 ₩22,316 ₩10,211.895 ₩40,242
Income before tax ₩23,874 ₩23,220 ₩9,858.532 ₩41,435
Income tax expense ₩6,462 ₩6,889 ₩8,641.741 ₩15,151
Minority interest ₩651 ₩682 ₩769.951 ₩771
Net income
Net income ₩17,465 ₩16,431 ₩1,264.65 ₩26,351
Income (for common shares) ₩17,465 ₩16,431 ₩1,264.65 ₩26,351
(in millions KRW) 2021 2020 2019
Revenue
Total revenue ₩413,937.974 ₩405,953.021 ₩360,967.098
Cost of revenue ₩224,172.902 ₩239,044.923 ₩265,788.109
Gross profit ₩189,765.072 ₩166,908.098 ₩95,178.989
Operating activities
Research & development ₩16,569.508 ₩15,033.944 ₩9,502.742
Selling, general & administrative ₩72,534.88 ₩60,378.514 ₩35,366.772
Total operating expenses ₩316,374.079 ₩316,478.828 ₩312,164.039
Operating income ₩97,563.895 ₩89,474.193 ₩48,803.059
Income from continuing operations
Net other income ₩1,736.637 -₩1,463.083 ₩2,453.444
EBIT ₩97,563.895 ₩89,474.193 ₩48,803.059
Income before tax ₩99,300.532 ₩88,011.11 ₩51,256.503
Income tax expense ₩33,420.741 ₩25,455.435 ₩11,526.299
Minority interest ₩769.951 ₩437.141 ₩221.351
Net income
Net income ₩65,946.65 ₩62,703.088 ₩39,875.981
Income (for common shares) ₩65,946.65 ₩62,703.088 ₩39,875.981

Cash flows

XSLX
XSLX
(in millions KRW) 29 Jun 2022 30 Mar 2022 30 Dec 2021 29 Sep 2021
Net income ₩17,465 ₩16,431 ₩1,264.65 ₩26,351
Operating activities
Depreciation
Change in accounts receivable
Changes in inventory
Total cash flows from operations
Investing activities
Capital expenditures
Investments
Other cash flows from investing
Total cash flows from investing
Financing activities
Dividends paid
Net borrowings
Other cash flows from financing
Total cash flows from financing
Effect of exchange rate
Change in cash and equivalents
(in millions KRW) 2021 2020 2019
Net income ₩65,946.65 ₩62,703.088 ₩39,875.981
Operating activities
Depreciation ₩5,229.853 ₩4,023.33 ₩2,846.308
Change in accounts receivable ₩5,529.558 -₩29,116.366 ₩30,143.064
Changes in inventory
Total cash flows from operations ₩74,182.958 ₩69,856.903 ₩26,371.282
Investing activities
Capital expenditures -₩1,747.427 -₩1,071.379 -₩982.899
Investments -₩78,289.126 -₩32,356.584 -₩30,274.357
Other cash flows from investing
Total cash flows from investing -₩82,471.756 -₩36,049.464 -₩32,525.784
Financing activities
Dividends paid
Net borrowings -₩3,647.934 -₩2,892.567 -₩2,034.071
Other cash flows from financing ₩341.915 ₩345.322 ₩347.996
Total cash flows from financing -₩3,306.019 -₩2,547.245 -₩1,686.075
Effect of exchange rate ₩67.278 -₩55.691 ₩1,217.818
Change in cash and equivalents -₩11,527.539 ₩31,204.503 -₩6,622.759

NHTC
Natural Health Trends Corp.
Compare

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Current assets
Cash $15.613 $25.862 $56.217 $58.449
Short term investments $33.087 $28.608
Net receivables
Inventory $4.25 $4.899 $4.293 $4.882
Total current assets $56.898 $62.733 $64.229 $66.969
Long term investments
Property, plant & equipment $3.256 $3.513 $3.585 $3.833
Goodwill & intangible assets
Total noncurrent assets $4.593 $4.906 $4.862 $4.852
Total investments $33.087 $28.608
Total assets $61.491 $67.639 $69.091 $71.821
Current liabilities
Accounts payable $0.653 $0.749 $0.99 $0.666
Deferred revenue $7.587 $7.174 $6.166 $6.248
Short long term debt $1.21 $1.199 $1.146 $1.182
Total current liabilities $22.129 $20.862 $19.984 $20.778
Long term debt $1.977 $2.219 $2.318 $2.539
Total noncurrent liabilities $2.112 $7.407 $7.507 $7.733
Total debt $3.187 $3.418 $3.464 $3.721
Total liabilities $24.241 $28.269 $27.491 $28.511
Stockholders' equity
Retained earnings -$21.948 -$19.818 -$17.703 -$15.757
Other stockholder equity -$1.249 -$1.221 -$1.069 -$1.267
Total stockholder equity $37.25 $39.37 $41.6 $43.31
(in millions USD) 2023 2022 2021
Current assets
Cash $56.217 $69.746 $84.365
Short term investments
Net receivables
Inventory $4.293 $4.525 $5.257
Total current assets $64.229 $77.551 $93.469
Long term investments
Property, plant & equipment $3.585 $4.386 $3.484
Goodwill & intangible assets
Total noncurrent assets $4.862 $5.266 $4.886
Total investments
Total assets $69.091 $82.817 $98.355
Current liabilities
Accounts payable $0.99 $0.81 $0.761
Deferred revenue $6.166 $5.597 $8.536
Short long term debt $1.146 $1.135 $1.239
Total current liabilities $19.984 $20.438 $24.656
Long term debt $2.318 $2.989 $1.928
Total noncurrent liabilities $7.507 $12.228 $14.211
Total debt $3.464 $4.124 $3.167
Total liabilities $27.491 $32.666 $38.867
Stockholders' equity
Retained earnings -$17.703 -$9.056 -$0.231
Other stockholder equity -$1.069 -$1.004 -$0.492
Total stockholder equity $41.6 $50.151 $59.488

Income statement

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Revenue
Total revenue $10.475 $10.951 $10.937 $10.615
Cost of revenue $2.699 $2.912 $2.789 $2.689
Gross profit $7.776 $8.039 $8.148 $7.926
Operating activities
Research & development
Selling, general & administrative $8.014 $8.404 $8.39 $8.218
Total operating expenses $8.014 $8.404 $8.39 $8.218
Operating income -$0.238 -$0.365 -$0.242 -$0.292
Income from continuing operations
EBIT $0.281 $0.198 $0.466 $0.293
Income tax expense $0.108 $0.01 $0.108 $0.121
Interest expense
Net income
Net income $0.173 $0.188 $0.358 $0.172
Income (for common shares) $0.173 $0.188 $0.358 $0.172
(in millions USD) 2023 2022 2021
Revenue
Total revenue $43.924 $49.134 $60.005
Cost of revenue $11.175 $12.661 $15.01
Gross profit $32.749 $36.473 $44.995
Operating activities
Research & development
Selling, general & administrative $34.42 $36.743 $43.424
Total operating expenses $34.42 $36.743 $43.424
Operating income -$1.671 -$0.27 $1.571
Income from continuing operations
EBIT $0.745 $0.602 $1.51
Income tax expense $0.177 $0.289 $0.425
Interest expense
Net income
Net income $0.568 $0.313 $1.085
Income (for common shares) $0.568 $0.313 $1.085

Cash flows

XSLX
XSLX
(in millions USD) 30 Jun 2024 31 Mar 2024 31 Dec 2023 30 Sep 2023
Net income $0.173 $0.188 $0.358 $0.172
Operating activities
Depreciation $0.307 $0.307 $0.313 $0.305
Business acquisitions & disposals
Stock-based compensation $0.038 $0.037 $0.038 $0.038
Total cash flows from operations -$3.568 $0.549 -$0.069 -$0.869
Investing activities
Capital expenditures -$0.019 -$0.011 -$0.014 -$0.018
Investments -$4.343 -$28.514
Total cash flows from investing -$4.362 -$28.525 -$0.014 -$0.018
Financing activities
Dividends paid -$2.303 -$2.303 -$2.304 -$2.303
Sale and purchase of stock
Net borrowings
Total cash flows from financing -$2.303 -$2.303 -$2.304 -$2.303
Effect of exchange rate -$0.016 -$0.076 $0.155 $0.034
Change in cash and equivalents -$10.249 -$30.355 -$2.232 -$3.156
(in millions USD) 2023 2022 2021
Net income $0.568 $0.313 $1.085
Operating activities
Depreciation $1.273 $1.376 $1.462
Business acquisitions & disposals
Stock-based compensation $0.161
Total cash flows from operations -$4.278 -$4.852 $1.016
Investing activities
Capital expenditures -$0.046 -$0.143 -$0.225
Investments
Total cash flows from investing -$0.046 -$0.143 -$0.225
Financing activities
Dividends paid -$9.215 -$9.138 -$9.138
Sale and purchase of stock
Net borrowings
Total cash flows from financing -$9.215 -$9.138 -$9.138
Effect of exchange rate $0.01 -$0.486 -$0.18
Change in cash and equivalents -$13.529 -$14.619 -$8.527

PCGH
Polar Capital Global Healthcare Trust Plc
Compare

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions USD) 31 Mar 2022 30 Sep 2021 31 Mar 2021 30 Sep 2020
Current assets
Cash $11.45 $13.72 $26.31 $17.84
Short term investments
Net receivables $2.66 $2.87 $0.83 $3.67
Inventory
Other current assets
Total current assets $14.11 $16.59 $27.14 $21.52
Long term investments $427.24 $408.56 $344.6 $342.4
Property, plant & equipment
Goodwill
Intangible assets
Other assets
Deferred long term asset charges
Total assets $441.35 $425.15 $371.74 $363.92
Current liabilities
Accounts payable
Short long term debt
Other current liabilities
Total current liabilities $0.44 $2.96 $0.34 $3.38
Long term debt $37.01 $36.47 $35.93 $35.41
Other liabilities
Deferred long term liabilities
Minority interest
Total liabilities $37.45 $39.42 $36.27 $38.79
Stockholders' equity
Stock option warrants
Common stock $31.04 $31.04 $31.04 $31.04
Retained earnings $292.18 $274.01 $223.74 $213.41
Treasury stock
Capital surplus
Other stockholder equity
Total stockholder equity $403.9 $385.73 $335.47 $325.13
Net tangible assets
(in millions USD) 2021 2020 2019
Current assets
Cash $13.72 $17.84 $6.86
Short term investments
Net receivables $2.86 $3.67 $17.91
Inventory
Other current assets
Total current assets $16.59 $21.52 $24.79
Long term investments $408.56 $342.4 $308.99
Property, plant & equipment
Goodwill
Intangible assets
Other assets
Deferred long term asset charges
Total assets $425.15 $363.92 $333.79
Current liabilities
Accounts payable $2.59 $2.53 $10.29
Short long term debt
Other current liabilities
Total current liabilities $2.96 $3.38 $10.96
Long term debt $36.47 $35.41 $34.37
Other liabilities
Deferred long term liabilities
Minority interest
Total liabilities $39.42 $38.79 $45.34
Stockholders' equity
Stock option warrants
Common stock $31.04 $31.04 $31.04
Retained earnings $274.01 $213.41 $176.72
Treasury stock
Capital surplus
Other stockholder equity
Total stockholder equity $385.73 $325.13 $288.45
Net tangible assets

Income statement

XSLX
XSLX
(in millions USD) 31 Mar 2022 30 Sep 2021 31 Mar 2021 30 Sep 2020
Revenue
Total revenue $21.96 $53.98 $13.73 $59.98
Cost of revenue $1.45 $1.36 $1.23 $1.38
Gross profit $20.51 $52.61 $12.5 $58.6
Operating activities
Research & development
Selling, general & administrative $0.35 $0.35 $0.26 $0.42
Non-recurring
Other operating expenses
Total operating expenses $1.81 $1.71 $1.49 $1.8
Operating income $20.16 $52.26 $12.24 $58.18
Income from continuing operations
Net other income
EBIT
Interest expense
Income before tax $19.61 $51.73 $11.72 $57.65
Income tax expense $0.23 $0.25 $0.17 $0.21
Minority interest
Net income from continuing ops
Non-recurring events
Discontinued operations
Extraordinary items
Effect of accounting change
Other items
Net income
Net income $19.39 $51.48 $11.55 $57.45
Income (for common shares) $19.39 $51.48 $11.55 $57.45
(in millions USD) 2021 2020 2019
Revenue
Total revenue $67.71 $45.25 $0.92
Cost of revenue $2.85 $3 $2.82
Gross profit $64.85 $42.25 -$1.9
Operating activities
Research & development $0.13 $0.09
Selling, general & administrative $0.35 $0.33 $0.26
Non-recurring
Other operating expenses $0.04
Total operating expenses $3.2 $3.47 $3.19
Operating income $64.51 $41.78 -$2.28
Income from continuing operations
Net other income $0.04
EBIT
Interest expense
Income before tax $63.44 $40.74 -$3.33
Income tax expense $0.42 $0.47 $0.54
Minority interest
Net income from continuing ops
Non-recurring events
Discontinued operations
Extraordinary items
Effect of accounting change
Other items
Net income
Net income $63.02 $40.27 -$3.86
Income (for common shares) $63.02 $40.27 -$3.86

Cash flows

XSLX
XSLX
(in millions USD) 31 Mar 2022 30 Sep 2021 31 Mar 2021 30 Sep 2020
Net income $20.16 $52.27 $12.24 $58.18
Operating activities
Depreciation
Net income adjustments
Change in accounts receivable
Changes in liabilities
Changes in inventory
Changes in other operating activities
Total cash flows from operations -$1.05 -$11.38 $9.68 $11.93
Investing activities
Capital expenditures
Investments
Other cash flows from investing
Total cash flows from investing
Financing activities
Dividends paid -$1.21 -$1.22 -$1.21 -$1.22
Sale and purchase of stock
Net borrowings
Other cash flows from financing -$0.01
Total cash flows from financing -$1.21 -$1.22 -$1.21 -$1.21
Effect of exchange rate
Change in cash and equivalents -$2.27 -$12.59 $8.46 $10.71
(in millions USD) 2021 2020 2019
Net income $64.51 $41.78 -$2.28
Operating activities
Depreciation
Net income adjustments
Change in accounts receivable
Changes in liabilities
Changes in inventory
Changes in other operating activities
Total cash flows from operations -$1.7 $14.58 -$1.28
Investing activities
Capital expenditures
Investments
Other cash flows from investing
Total cash flows from investing
Financing activities
Dividends paid -$2.43 -$2.55 -$2.44
Sale and purchase of stock
Net borrowings
Other cash flows from financing -$1.05 -$1.56
Total cash flows from financing -$2.43 -$3.59 -$4
Effect of exchange rate
Change in cash and equivalents -$4.13 $10.99 -$5.28

SCP
Schroder UK Mid Cap Fund Plc
Compare

Profit margin

Debt to assets

Cash flow

Balance sheet

XSLX
XSLX
(in millions GBP) 31 Mar 2024 31 Mar 2023
Current assets
Cash £1.38 £5.85
Short term investments
Net receivables £0.893 £1.67
Inventory
Other current assets
Total current assets £2.28 £7.52
Long term investments £248.75 £235.37
Property, plant & equipment
Goodwill
Intangible assets
Other assets
Deferred long term asset charges
Total assets £251.03 £242.89
Current liabilities
Accounts payable £2.15
Short long term debt £20 £25
Other current liabilities £0.535 £0.532
Total current liabilities £22.68 £25.53
Long term debt
Other liabilities -£10 -£25
Deferred long term liabilities
Minority interest
Total liabilities £22.68 £25.53
Stockholders' equity
Stock option warrants
Common stock £8.64 £8.64
Retained earnings £195.7 £184.72
Treasury stock
Capital surplus
Other stockholder equity £10.03 £10.03
Total stockholder equity £228.34 £217.36
Net tangible assets
(in millions GBP) 2022
Current assets
Cash £4.79
Short term investments
Net receivables £0.853
Inventory
Other current assets
Total current assets £5.64
Long term investments £207.29
Property, plant & equipment
Goodwill
Intangible assets
Other assets
Deferred long term asset charges
Total assets £212.93
Current liabilities
Accounts payable
Short long term debt £25
Other current liabilities £0.535
Total current liabilities £25.54
Long term debt
Other liabilities -£25
Deferred long term liabilities
Minority interest
Total liabilities £25.54
Stockholders' equity
Stock option warrants
Common stock £8.64
Retained earnings £154.75
Treasury stock
Capital surplus
Other stockholder equity £10.03
Total stockholder equity £187.39
Net tangible assets

Income statement

XSLX
XSLX
(in millions GBP) 31 Mar 2024 31 Mar 2023
Revenue
Total revenue £10.76 £18.08
Cost of revenue
Gross profit £10.76 £18.08
Operating activities
Research & development
Selling, general & administrative £0.61 £0.538
Non-recurring
Other operating expenses £0.298 £0.136
Total operating expenses £0.61 £0.538
Operating income £10.15 £17.54
Income from continuing operations
Net other income £0.298 £0.136
EBIT
Interest expense -£0.298 -£0.136
Income before tax £9.85 £17.4
Income tax expense
Minority interest
Net income from continuing ops
Non-recurring events
Discontinued operations
Extraordinary items
Effect of accounting change
Other items £0.298 £0.136
Net income
Net income £9.85 £17.4
Income (for common shares) £9.85 £17.4
(in millions GBP) 2022
Revenue
Total revenue -£79.36
Cost of revenue
Gross profit -£79.36
Operating activities
Research & development
Selling, general & administrative £2.16
Non-recurring
Other operating expenses £0.387
Total operating expenses £2.16
Operating income -£81.53
Income from continuing operations
Net other income £0.387
EBIT
Interest expense -£0.387
Income before tax -£81.92
Income tax expense
Minority interest
Net income from continuing ops
Non-recurring events
Discontinued operations
Extraordinary items
Effect of accounting change
Other items £0.387
Net income
Net income -£81.92
Income (for common shares) -£81.92

Cash flows

XSLX
XSLX
(in millions GBP) 30 Mar 2022 30 Dec 2021 29 Sep 2021 29 Jun 2021
Net income -£15.6335 -£15.6335 £17.4015 £17.4015
Operating activities
Depreciation
Net income adjustments
Change in accounts receivable
Changes in liabilities
Changes in inventory
Changes in other operating activities
Total cash flows from operations
Investing activities
Capital expenditures
Investments
Other cash flows from investing
Total cash flows from investing
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings
Other cash flows from financing
Total cash flows from financing
Effect of exchange rate
Change in cash and equivalents
(in millions GBP) 2021 2020 2019
Net income £82.709 -£16.929 £3.202
Operating activities
Depreciation
Net income adjustments
Change in accounts receivable
Changes in liabilities
Changes in inventory
Changes in other operating activities
Total cash flows from operations
Investing activities
Capital expenditures
Investments
Other cash flows from investing
Total cash flows from investing
Financing activities
Dividends paid
Sale and purchase of stock
Net borrowings
Other cash flows from financing
Total cash flows from financing
Effect of exchange rate
Change in cash and equivalents